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March 9, 2010:1051–4lar assist devices (VADs), including the provision of physical
xercise, nutrition, and routine self-care, as well as the coordina-
ion of effective communication among heart failure (HF) special-
sts, primary care providers, and first responders. The authors also
ecognize that adequate cardiac rehabilitation (CR) plays a central
ole in a patient’s recovery yet lamented that this is often difficult
o carry out for patients with VADs in a typical community setting,
ecause community rehab programs might be uncomfortable with
nrolling these patients.
As fellows of the American Association of Cardiovascular and
ulmonary Rehabilitation (AACVPR), we encourage profession-
ls who work in HF teams to reach out to AACVPR certified
rograms in their communities (2) to develop collaborative rela-
ionships to develop safe, effective CR environments. We also
elcome the opportunity to use the information from this article to
evelop educational programs for our members to help them serve
hese patients.
Cardiac rehabilitation is an excellent environment to reinforce
elf-management; provide emotional support; and increase exercise
olerance, functional capacity, and quality of life (3). Patients who
eceive VADs have been unable to perform much activity and have
ecome debilitated by the inherent disease process and prolonged
ed rest. This group would particularly benefit from CR to restore
hem to an acceptable physical function and provide education and
ounseling that would complement the education afforded by the
F team.
Although many insurance carriers do not currently cover mon-
tored (Phase 2) CR for patients with HF, efforts are ongoing to
ncourage such coverage. In the meantime, patients with HF are
overed by most insurance plans for Phase 2 CR if they have a
ualifying diagnosis (recent myocardial infarction, coronary artery
ypass surgery, percutaneous coronary intervention, heart valve
urgery, or heart transplantation). Alternatively, they can partici-
ate in a self-pay maintenance CR program (Phase 4, approximate
ost of $50 to $60/month), if deemed appropriate by their medical
are provider and by the CR team.
We agree with Wilson et al. (1) that a strong collaborative
elationship between HF and CR teams is essential to provide
ptimal care for patients with VADs and encourage cardiovascular
pecialists and professional associations devoted to improving care
or patients with HF to join with AACVPR to help make this
appen for our patients.
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1) and endorse their recommendations regarding physical therapy
nd rehabilitation for ventricular assist device (VAD) patients. As
he number of patients implanted with a VAD increases and as
hey transition back into their local communities, it is imperative
hat there is an increased awareness and knowledge of this unique
atient population. We strongly agree that cardiologists and heart
ailure specialists in particular need to reach out and develop a
ollaborative relationship with cardiac rehabilitation programs in
he development and implementation of an optimal environment
or the recovery of VAD patients. Although no large-scale trials
ave been performed to date, many VAD patients are debilitated
fter surgery and, like those individuals after cardiac transplanta-
ion, will benefit from an exercise rehabilitation program incorpo-
ating both muscular-strength and aerobic training (2). Additional
enefits of a strong multidisciplinary program include education
egarding nutrition and weight loss, lipid management, and
moking cessation as well as the positive reinforcement that comes
rom meeting others living with cardiovascular disease.
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